SignatureFD
MAZE icon

SignatureFD’s Maze Therapeutics MAZE Stock Holding History

SignatureFD’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$462 Hold
17
– – ﹤0.01% 3423
2026
Q2 		$507 Sell
17
-152
-90% -$3.98K ﹤0.01% 3357
2026
Q1 		$5.04K Buy
169
+155
+1,107% +$6.84K ﹤0.01% 2780
2025
Q4 		$580 Buy
+14
New +$481 ﹤0.01% 3215

Other funds holding MAZE

Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Mass General Brigham
Mass General Brigham Somerville, Massachusetts $456M AUM 27.51% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

SignatureFD's MAZE Position: Q3 2026 in Review

SignatureFD held its Maze Therapeutics (MAZE) position steady in Q3 2026 at 17 shares worth $462. The position accounts for ﹤0.01% of the portfolio, ranked #3423.

SignatureFD first reported a position in MAZE in Q4 2025 and has held it in 4 quarters since. The position peaked at $5.04K in Q1 2026. 47 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.

  • SignatureFD held 17 shares of Maze Therapeutics worth $462 as of Q3 2026.
  • SignatureFD left its Maze Therapeutics share count unchanged in Q3 2026.
  • Maze Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3423 holding.
  • SignatureFD first reported a position in Maze Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • SignatureFD's Maze Therapeutics position peaked at $5.04K in Q1 2026.
  • 47 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.